Editorial: The global #monkeypox outbreak raises urgent concerns about overlooked complications, including ophthalmological issues. Studies highlight a 2x higher risk of uveitis in monkeypox patients. Clinicians must stay vigilant for intraocular inflammation. https://lnkd.in/eYNbYFtp #Ophthalmology
Eye’s Post
More Relevant Posts
-
Pulmonary alveolar proteinosis, typically associated with autoimmune disorders, can also occur due to rare infections such as Bacillus megaterium, according to a recent case study. View the complete article below ⤵️ #AutoImmune #AutoImmuneDisease #PulmonaryAlveolarProteinosis #Pulmonology
To view or add a comment, sign in
-
𝐄𝐚𝐫 𝐈𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟑𝟒 ▶𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/dvD86M_7 The Ear Infection Treatment Market, valued at USD 7.94 billion in 2021, is projected to reach USD 14 billion by 2031, growing at a CAGR of 11.6% over the forecast period. Ear infections, caused by bacteria, viruses, or foreign particles, lead to ear inflammation and are treated with medications or surgeries like myringotomy, which involves removing a small portion of tissue from the eardrum to promote drainage and prevent fluid build-up that can cause hearing loss. Treatments include antibiotics, anti-inflammatory medicines, draining pus, warm compresses, and painkillers. The market's growth is driven by rising incidences of chronic and acute disorders, increased awareness of ear infection prevention, and a surge in international travel. Children are more susceptible to ear infections than adults, and various entities, including governments, NGOs, and businesses, are enhancing clinical support and patient treatment to address this issue. 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: ▶𝐓𝐲𝐩𝐞: Inner Ear, Middle Ear, Outer Ear. ▶𝐁𝐲 𝐏𝐚𝐭𝐡𝐨𝐠𝐞𝐧𝐬: Bacteria, Viruses, Others. ▶𝐁𝐲 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭: Drugs, Surgery, Others. ▶𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫: Hospitals, Clinics, Others. ▶𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧: North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA). 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐜𝐨𝐯𝐞𝐫𝐞𝐝: Sanofi, Novartis, Janssen Inc., Abbott, Pfizer, Medtronic, Olympus Corporation, TORQUE PHARMACEUTICALS PVT. LTD., American Diagnostic Corporation, Intersect ENT, Inc., Now Part of Medtronic. #EarInfection #OtitisMedia #EarCare #ENTHealth #HearingHealth #EarHealth #EarPain #ENTSpecialist #HearingLoss #PediatricENT #EarInfectionTreatment #MiddleEarInfection #Antibiotics #ENTCare #HearingAid #EarInfectionRelief #HearingSolutions #HealthcareInnovation #PatientCare #MedicalDevices
To view or add a comment, sign in
-
-
Making improvements in Life possible - powered by our QIAstat- Dx platform
🦠 STEC infections are particularly risky for the very young and old. Early detection is crucial for effective treatment. 🚨 But did you know? Many tests overlook the emerging STEC Shiga toxin subtype stx2f, which could delay and complicate treatment plans. ✅ Our QIAstat-Dx Gastrointestinal Panel 2 is leading the charge by ensuring you can easily detect both stx1 and stx2 subtypes, including stx2f. Armed with this precise diagnostic information, clinicians can make informed decisions about early volume expansion to improve patient outcomes. Learn how our test can support your practice 👉 https://lnkd.in/ehdC_aJZ
To view or add a comment, sign in
-
📢New Study Reviews Botulinum Toxin Treatment for Sialorrhea in Severe Brain Injury Patients 📢 Sialorrhea is a condition where an individual cannot control saliva within their mouth. It is a challenging consequence of brain injury which can lead to drooling and contribute to chest infections through salivary aspiration. Our latest research reviewed 79 salivary gland botulinum toxin (SG-BoNT) treatments given to 49 people with severe ABI. We found that SG-BoNT injections are: ✅Clinically effective in reducing drooling severity. ✅Associated with significantly fewer chest infections, especially with repeated treatments or higher doses. ✅Safe, with no adverse events reported in our study. Notably, the observed reduction in chest infection frequency represents a novel finding in this population. 📖 Read more about how SG-BoNT treatments are making a difference in specialist care for ABI. https://lnkd.in/ejxAN_Ep #NeuroRehabilitation #BrainInjuryCare #MedicalResearch #SialorrheaTreatment #HealthcareInnovation
To view or add a comment, sign in
-
Came across an interesting article which discusses the common symptom of urinary tract infection (UTI) which is dysuria may not necessarily mean that a person has UTI. In post menopausal women dysuria along with a negative urine culture indicates they have a condition called “Genitourinary syndrome of menopause” or GSM. Empirical treatment with antibiotics will not resolve the symptoms and will only lead to the added burden of antimicrobial resistance. Proper treatment includes vaginal estrogen which will resolve the condition. More details can be found in the link below 👇 https://lnkd.in/g3UDetSm
To view or add a comment, sign in
-
Acta Scientific Gastrointestinal Disorders Journal’s publication in Volume 7 Issue 4 Article Title: Outcomes of a randomised controlled trial (Feasibility Study) of prophylactic pyloric balloon dilatation during ivor lewis esophagectomy to prevent delayed gastric emptying. Abstract: Early delayed gastric emptying (DGE) occurs in up to 37% of patients following esophagectomy. This can contribute to increased anastomotic leak and respiratory infection rates. Find Complete Article at below link: https://lnkd.in/gESKaAX2 Submit your articles to give it the deserving global reach Contact us : + 91-91548-70057 Email us: gastro@actascientific.com #drugdiseases #ewingsarcoma #feasibilitystudy #prophylacticpyloric #balloondilatation #ivorlewis #metastasis #esophageallining #esophagectomy #gastricepithelia #prostaglandinsynthesis #longgastricemptying #ironsupplements #pneumatosisintestinalis #gastricemptying
To view or add a comment, sign in
-
-
ICYMI: Cornea Update: Overview of Mycotic Keratitis: Abstract: Keratomycosis is a serious corneal infection associated with high ocular morbidity that can lead to severe vision loss. It is estimated to affect more than 1 million patients annually, most commonly occurring in tropical climates, and represents a growing threat to patients worldwide. Despite aggressive medical management, fungal infections have a higher rate of perforation requiring surgical intervention compared with other infectious etiologies. Early diagnosis and appropriate treatment are keys to preserving vision and saving patients' eyes. http://dlvr.it/T731GY #Cornea #Ophthalmology #Ophthotwitter
To view or add a comment, sign in
-
Bacterial meningitis is a severe infection causing inflammation of the membranes surrounding the brain and spinal cord. Symptoms include sudden fever, severe headache, and stiff neck, often progressing to confusion, seizures, and coma. Without prompt treatment with antibiotics, it can lead to septicemia, brain damage, or death. The mortality rate varies but can be as high as 20-30% even with treatment, due to rapid progression and complications like swelling or stroke. HEALTH NEWS CDC warns of increase in bacterial illnesses that can lead to meningitis and possibly death Cases this year appear to be on track to surpass 2023's total, health officials said. five colonies of Group-B Neisseria meningitidis bacteria. A 1966 microscope photo of five colonies of Group-B Neisseria meningitidis bacteria. The CDC issued an alert Thursday to U.S. doctors about an increase in cases of one type of invasive meningococcal disease, mostly due to the serogroup Y strain of the bacteria. Dr. Brodsky / CDC via AP
To view or add a comment, sign in
-
Featured in Times Of India! Understanding hMPV: Key Symptoms and Insights from Dr. Shubham Vatsya, Senior Consultant in Gastroenterology and Hepatology. Learn how this infection differs from COVID-19 and why staying informed is crucial for your health. To consult with Dr. Shubham Vatsya Call us at - 9910778029 #hmpv #virus #stayalert #LiverCare #GutFriendly #StomachHealth #HealthyDigestiveSystem #Gastroenterologist
To view or add a comment, sign in
-
-
🦠 STEC infections are particularly risky for the very young and old. Early detection is crucial for effective treatment. 🚨 But did you know? Many tests overlook the emerging STEC Shiga toxin subtype stx2f, which could delay and complicate treatment plans. ✅ Our QIAstat-Dx Gastrointestinal Panel 2 is leading the charge by ensuring you can easily detect both stx1 and stx2 subtypes, including stx2f. Armed with this precise diagnostic information, clinicians can make informed decisions about early volume expansion to improve patient outcomes. Learn how our test can support your practice 👉 https://lnkd.in/ehdC_aJZ
To view or add a comment, sign in